bullish
Hugel: Botulinum Injects Sales from Exports
259 Views10 Aug 2017 13:21
Strong sales momentum, low price volatility versus the Korean market,and improving asset turnover relative to its sector
In April, Hugel signed a...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Rising
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
- Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)20 Apr 2022
- The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?15 Aug 2021
- Hugel Placement: A 5.2% Block Deal Sale29 Jun 2020
- Hugel: Botulinum Injects Sales from Exports10 Aug 2017
x